Literature DB >> 22914320

Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma.

Tohru Nakagawa1, Yae Kanai, Hiroyuki Nakanishi, Motokiyo Komiyama, Hiroyuki Fujimoto.   

Abstract

OBJECTIVE: The aim of this study was to identify clinicopathological variables associated with the clinical outcomes of patients with lymph node metastasis-positive urothelial bladder carcinoma after radical cystectomy.
METHODS: Forty-six patients who underwent radical cystectomy without preoperative chemotherapy and had histologically proven nodal metastasis were included in the study. The status of lymph nodes and primary lesion was analyzed in terms of disease-specific survival and recurrence-free survival.
RESULTS: The 5-year disease-specific survival and recurrence-free survival for the 46 patients overall were 41.3 and 32.2%, respectively. Univariate analysis showed that pN status, the total number of involved lymph nodes, lymph node density and extranodal invasion were statistically significant variables predictive of disease-specific survival. Multivariate analysis revealed that the total number of involved lymph nodes, extranodal invasion and diameter of the metastatic lesion were statistically significant variables predictive of disease-specific survival. Interestingly, the diameter of metastatic lesions was inversely correlated with poorer survival. Patients with large (≥10 mm) metastatic lesions and no extranodal invasion (expansive growth) had significantly better disease-specific survival than those with multiple small (<10 mm) metastatic lesions and no extranodal invasion (highly spreading) (P=0.0156) or those with extranodal invasion (infiltrative growth) (P=0.0181).
CONCLUSIONS: Our data indicate that the clinical outcome of node-positive patients is not only stratified according to the tumor burden reflected in the total number of involved lymph nodes, but also affected by tumor biology including invasiveness and potential for metastasis, which is reflected in pathological characteristics such as extranodal invasion and the diameter of metastatic lesions.

Entities:  

Mesh:

Year:  2012        PMID: 22914320     DOI: 10.1093/jjco/hys136

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  2 in total

1.  Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: a review of SEER data, 2004-2010.

Authors:  Mary E Charlton; Margaret Peggy Adamo; Leon Sun; Sundeep Deorah
Journal:  Cancer       Date:  2014-12-01       Impact factor: 6.860

2.  Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy.

Authors:  Marisa M Clifton; Sarah P Psutka; Stephen A Boorjian; John C Cheville; Prabin Thapa; R Houston Thompson; Matthew K Tollefson; R Jeffrey Karnes; Igor Frank
Journal:  World J Urol       Date:  2014-05-15       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.